Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 17, 2007
- Accepted for publication July 30, 2007
- Published online October 31, 2007.
Article Versions
- previous version (October 17, 2007 - 12:32).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2007 by Society of Nuclear Medicine
Author Information
- Bruce E. Hillner 1 ,
- Dawei Liu 2 ,
- R. Edward Coleman 3 ,
- Anthony F. Shields 4 ,
- Ilana F. Gareen 2 ,
- Lucy Hanna 2 ,
- Sharon Hartson Stine 5 and
- Barry A. Siegel 6
- 1Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia; 2Center for Statistical Sciences, Brown University, Providence, Rhode Island; 3Department of Radiology, Duke University School of Medicine, Durham, North Carolina; 4Karmanos Cancer Institute, Wayne State University, Detroit, Michigan; 5American College of Radiology, Philadelphia, Pennsylvania; and 6Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
- For correspondence or reprints contact: Bruce E. Hillner, MD, Virginia Commonwealth University, 1101 E. Marshall St., Room 7013, Richmond, VA 23298-0170. E-mail: Hillner{at}vcu.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- The Australasian Radiopharmaceutical Trials Network: Clinical Trials, Evidence, and Opportunity
- The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement
- Hospice Admission and Survival After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
- Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry
- A Flexible, Multifaceted Approach Is Needed in Health Technology Assessment of PET
- Impact of 18F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry
- Impact of 18F-Fluoride PET in Patients with Known Prostate Cancer: Initial Results from the National Oncologic PET Registry
- Intended Versus Inferred Care After PET Performed for Initial Staging in the National Oncologic PET Registry
- Impact of 18F-FDG PET Used After Initial Treatment of Cancer: Comparison of the National Oncologic PET Registry 2006 and 2009 Cohorts
- A Broader Importance of NOPR to the Future of Nuclear Imaging
- New Pathways to Medicare Coverage for Innovative PET Radiopharmaceuticals: Report of a Medical Imaging & Technology Alliance (MITA) Workshop
- Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
- Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
- PET and PET/CT Reports: Observations from the National Oncologic PET Registry
- Prospective Study of [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma
- NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types
- Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry
- Registries That Show Efficacy: Good, but Not Good Enough
- Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry